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FREQUENCY OF HEPATITIS B IMMUNITY AND OCCUPATIONAL EXPOSURES TO BODY FLUIDS 
AMONG BRAZILIAN MEDICAL STUDENTS AT A PUBLIC UNIVERSITY
Luiz Carlos Marques de OLIVEIRA(1) & João Paulo Jordão PONTES(2)
SUMMARY
In the present study the frequencies of immunity against hepatitis B (HB) and of potentially contaminating accidents among 
medical students of a Brazilian public university were evaluated. Of all the 400 students who should have been immunized, 303 
(75.7%), 66.3% of whom were women, answered an anonymous, self-administered questionnaire. Serum anti-HBs were determined 
in 205 of them and titers ≥ 10 UI/L were considered to be protective. A total of 86.8% of students had received three doses of HB 
vaccine. The frequency of immunity among women (96.4%) was higher (p = 0.04) than that among men (87.7%). Among those who 
did not have immunity, 12/13 (92.3%) had been vaccinated before entering medical school. Only 11% of the students with complete 
vaccination had previously verified serological response to the vaccine. A total of 23.6% reported having been somehow exposed to 
blood or secretions. Among final-year students, this frequency was 45.0%, being similar among men (47.8%) and women (43.2%). Of 
all these accidents, 57.7% were due to body fluids coming in contact with mucosa and 42.3% due to cut and puncture accidents. The 
results from this study show that: 1) the frequency of immunity against HB is high among the evaluated medical students, although 
verification of response to vaccination is not a concern for them; 2) anti-HBs titers should be verified after complete vaccination and 
on a regular basis, especially by men; and 3) the frequency of potentially contaminating accidents is high. 
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INTRODUCTION
Healthcare workers are a group at risk of acquiring occupational 
infections after accidental contact with blood or body fluids contaminated 
with a virus, bacterium, parasite or yeast; the human immunodeficiency 
virus (HIV) or those of hepatitis B (HBV) or C (HCV) account for most 
of this risk worldwide22. After parenteral exposure with a needle stick or 
sharp object contaminated by blood infected with HIV, HCV or HBV, the 
risk of acquiring the infection is 0.3%, 1.8% and about 30%, respectively, 
among susceptible individuals23.
HBV also has been demonstrated to survive in dried blood at room 
temperature on environmental surfaces for at least one week, and the 
potential for HBV transmission through contact with environmental 
surfaces has been demonstrated in investigations of HBV outbreaks 
among patients and professionals of hemodialysis units23. Infection by 
HBV can be prevented through vaccination, which is considered safe, 
efficient and cost effective27.
Anti-hepatitis B (HB) vaccine was included into the basic vaccination 
schedule in Brazil in September 1998, with the first dose being given 
at birth. In the public health network, this vaccine is also freely offered 
to children and adolescents aged up to 19 years, who have not been 
vaccinated, and to those belonging to HB risk groups2. Anti-HB 
immunization is performed with the application of three doses of the 
vaccine (0, 1 and 6 months).
Medical students, during their training, are a group of risk to 
accidental exposure to blood and body fluids due to inexperience and lack 
of ability in procedures with patients6,8,12,13,15,17,21. Students enrolled in the 
medical course of the Faculdade de Medicina da Universidade Federal 
de Uberlândia, who have not received the vaccine against hepatitis B 
(HB), are encouraged to be vaccinated during the pre-clinical course (the 
first two years of the six-year course) and this vaccine is provided at no 
cost. The present study aimed to assess the frequencies of vaccination 
against HBV and hepatitis B immunity among these students. In addition, 
the frequency of potentially contaminating accidents was also assessed 
during their academic qualification. 
METHODS
This study was performed among medical students of the Faculdade 
de Medicina da Universidade Federal de Uberlândia (FAMED/UFU), in 
the state of Minas Gerais, Brazil, in the first semester of 2009. Students 
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were collectively approached in the classrooms or wherever practical 
activities were conducted, when the objective of the study was clarified. 
An anonymous, self-completion questionnaire was subsequently 
distributed to obtain information about anti-hepatitis B vaccination 
status, with questions that included time of vaccination, number of 
doses received and whether he/she had had their serological response to 
vaccination checked. This questionnaire also included questions about 
socio-demographic data (sex, age), height, weight, smoking habit, 
and whether the student had a disease or used medication that could 
compromise the immune system. This questionnaire was distributed 
among 400 medical students who should have received three doses of 
anti-HBV vaccine, i.e. those enrolled in the 2nd through 6th academic 
years. Each respondent had received at least one 20 µg intramuscular 
dose of recombinant DNA vaccine (Euvax B®, LG Life Sciences, Korea) 
against HBV in the deltoid region. Moreover, they were all offered 
the opportunity to have free serological tests performed to verify their 
immunity status. 
Although this study was not designed to accurately assess the risks 
of accidental infection in these students, another questionnaire with 
questions about frequency of accidents with needles/sharp objects and 
patients’ secretions coming in contact with the mucosa, in addition to the 
procedures adopted in such cases, was also distributed to all 320 students 
enrolled in the 3rd through 6th academic years. Between the 3rd and 6th 
academic years, medical students perform activities in outpatient clinics, 
hospital and laboratories, where there are risks of occupational exposure. 
Determination of antibodies to the hepatitis B surface antigen (anti-
HBs) was performed using microparticle immunoenzymatic assay 
(AxSYM AUSAB, Abbott, Wiesbaden, Germany), at least one month 
after the last dose of vaccine, and serum levels equal to or higher than 10 
IU/L were considered protective. In addition, the possibility of previous 
contact with the HBV was verified by determining total antibodies to the 
hepatitis B core antigen (anti-HBc) with microparticle immunoenzymatic 
assay (AxSYM CORE, Abbott, Wiesbaden, Germany). Determinations 
of serological markers of HBV infection are not routinely performed 
before anti-HB vaccination among medical students at FAMED/UFU. 
Parameters such as body mass index (BMI) and smoking were also 
assessed. 
With regard to the statistical analysis, Student’s t-test was used to 
compare means of ages; Chi-square test or Fisher’s exact test, to compare 
frequencies of immunities among students; and Mann-Whitney test, 
to compare the medians of serum levels of anti-HBs. P values < 0.05 
were considered significant. This research project was approved by 
the institution’s Research Ethics Committee and a written consent was 
obtained from each student participating in this study. 
RESULTS
Of all students approached, 303 completed the questionnaire 
about anti-HB vaccination, 201 of whom (66.3%) were women, with a 
mean age (standard deviation) of 23.1 ± 2.2 years (between 18 and 27 
years), and 102 (33.7%) were men, with a mean age of 23.4 ± 2.2 years 
(between 18 and 32 years). It was observed that 263 students (86.8%) 
had received all three doses of vaccine against HBV recommended, of 
which 176 (66.9%) were women and 87 (33.1%) were men. Of these, 
156/263 (59.3%) had been vaccinated before entering medical school, 
while the others began to be vaccinated during the second semester of 
the first pre-clinical year. Among the 40 (13.2%) students who had not 
received all vaccines, three (1.0%) had received only one dose and 37 
(12.2%) had received two doses, and the reasons for the vaccination 
scheme to be incomplete were as follows: lack of interest (three [7.5%]), 
forgetfulness (14 [35%]) and ongoing vaccination (23 [57.5%]). Of all 
the students who had received all vaccines, only 29 (11%) had verified 
their immunity by having antibody titers determined, prior to this study. 
Antibody titers were determined in 205/303 (67.6%) students, of 
which 186 (90.7%) had serum levels of anti-HBs higher than 10 IU/L. 
When only students who had received all three doses were considered 
(N = 184), the frequency of immunity was 92.9% (171 students), being 
higher (p < 0.01) than that among those who had received one (one of 
three students [33.3%]) or two (14 of 18 students [77.8%]) doses of the 
vaccine. Among students with complete HBV vaccination schedule, the 
frequency of immunity was higher in women than men, and also higher 
in men who had received the vaccines during the medical course, when 
compared to those who had received them before the medical course 
(Table 1). Serum levels of anti-HBs were higher in women than men 
and also among students who had received the vaccine during their pre-
clinical course, when compared to those who had been vaccinated before 
entering university (Table 2). Two students had a BMI higher than 24.9 
and three were smokers; all these five students had immunity against HB. 
Table 1 
Frequency of immunity against hepatitis B observed in Brazilian medical 
students of a public university, who received 1, 2 or 3 doses of the HB vaccine 
Number of doses
/Gender/(N)
Serum anti-HBs antibodies p
Negative Positive
N % N %
1 dose
Male (1) 1 100 0 0 -
Female (2) 1 50.0 1 50.0
2 doses
Male (4) 2 50.0 2 50.0 0.20
Female (14) 2 14.3 12 85.7
3 doses
Male 
  BSV (40) 8 20.0 32 80.0 0.03*
  DSV (33) 1 3.0 32 97.0
  Subtotal (73) 9 12.3 64 87.7**
Female
  BSV (59) 4 6.8 55 93.2 0.12
  DSV (52) 0 0 52 100
  Subtotal (111) 4 3.6 107 96.4**
TOTAL (205) 19 9.3 186 90.7
BSV = before medical school vaccination; DSV = during medical school vac-
cination; N = number of students; *DSV > BSV; **p = 0.04: female > male. 
Fisher’s exact test.
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Among the students who had received one dose of the HB vaccine, 
one out of two women and only one man did not have immunity, and 
among those who had received two doses of the vaccine, 2/4 (50%) men 
and 12/14 (85.7%) women had immunity (Table 1), with a median of 
serum levels of anti-HBs of 36 IU/L and 50.4 IU/L, respectively. 
Students who had received all vaccines against HBV before entering 
university were those who most frequently had no immunity (12/13 
[92.3%]) and, among students who had immunity, the median of serum 
anti-HBs titers were lower than among those who had been vaccinated 
during their course of medicine (Table 2). Serum levels of anti-HBs higher 
than 100 IU/L were observed in 44/59 (74.6%) women who had been 
vaccinated before entering the school of medicine and in 46/52 (88.5%) 
women who had been vaccinated during the pre-clinical course (p = 0.10). 
Among men, anti-HBs levels higher than 100 IU/L were found in 17/40 
(42.5%) students who had been vaccinated before entering the school 
of medicine and in 28/33 (84.8%) who had been vaccinated during the 
pre-clinical course (p = 0.00). Tests to determine total anti-HBc were 
performed in the serum of 205 students who were submitted to anti-HBs 
determinations, all of whom were negative. 
Among students enrolled in the 3rd through 6th academic years, 220 
completed the questionnaire about occupational accidents. Of these, 52 
(23.6%) reported having been somehow exposed to blood or secretions 
(Table 3). Among last-year students, this frequency was 45.0% (27/60 
students), being similar (p = 0.94) among men (11/23 [47.8%]) and 
women (16/37 [43.2%]). Of all these accidents, 30 (57.7%) were due 
to body fluids coming in contact with mucosa and 22 (42.3%) due to 
cut and puncture accidents. Among the 52 students with biological 
accidents, 23 (44.2%) sought medical care and none were submitted to 
chemoprophylaxis; all patients with whom these students had an accident 
underwent serological tests, which were negative for HIV, HBV and HCV. 
Of all 29 students (55.8%) who did not report an incident, 19 (65.5%) 
did not find the occurrence relevant and 10 (34.5%) felt embarrassed 
to do this. 
DISCUSSION
In this study, the frequency of immunity against HBV among students 
with a complete course of vaccination (92.9%) is within the expected 
range of seroconversion in populations of immunocompetent young 
adults, varying between 90% and 95%27. The frequency of immunity 
was higher in female students than males, and poorer response to this 
vaccine in men has been observed in some studies1,25. The median of 
serum levels of anti-HBs was also higher in females than in males, both 
among students who had been vaccinated before entering the school of 
medicine and those who had been vaccinated during the pre-clinical 
course. Serum levels of anti-HBs, higher in females than males after 
HB vaccination, were described both in children who had received the 
first dose of vaccine at birth9 and in individuals who had been vaccinated 
during adulthood16. 
According to the U.S. Public Health Service, serum levels of anti-
HBs equal to or higher than 10 IU/L are protective against HBV23. With 
this parameter, about 10% of the students assessed could be at risk of 
acquiring hepatitis B. Among the students who had no immunity, the 
majority (92.3%) had been previously vaccinated when enrolling in the 
school of medicine. It cannot be concluded whether they did not respond 
to vaccination or whether there was a reduction in serum anti-HBs titers. 
Anti-HBs titers induced by vaccination declines, often rapidly, in the 
months or years following a complete course of primary immunization; 
the decrease is faster in the first 12 months and slower in subsequent 
years27. As these students have no serological evidence of contact with 
HBV, they should receive a booster dose to verify if there is anamnestic 
antibody response; in case they do not have this response, they should 
complete a second three-dose series of vaccine25. The chance to respond 
to a second series of three doses varies between 30% and 50%23.
To date, none of the international guidelines recommended booster 
doses for regular bases, and the results of one recent meta-analysis 
study showed that the protection provided by HB vaccine remains for 
at least two decades in the great majority of adequately-vaccinated 
immunocompetent individuals14. However, in certain countries, a serum 
anti-HBs titer equal to or higher than 100 IU/L has been adopted as 
protective immunity, and health professionals with levels between 10 and 
99 IU/L have been instructed to receive a booster dose of the vaccine7,18,27. 
In addition, it has been suggested that healthcare workers with anti-HBs 
concentrations lower than 100 IU/L should receive a booster dose every 
two years and their response monitored four weeks after this booster 
Table 2
Median values of anti-HBs serum levels after complete vaccination of Brazilian 
medical students of a public university (N = 184)
Gender Serum anti-HBs levels (IU/L) P
Median Range
Female
BSV (N = 59) 406 0 - > 1000 0.01*
DSV (N = 52) 1000 0 - > 1000
Total (N = 111) 576** 0 - > 1000
Male
BSV (N = 40) 82 0.8 - > 1000 0.00*
DSV (N = 33) 314 7.5 - > 1000
Total (N = 73) 141** 0.8 - > 1000
BSV = before medical school vaccination; DSV = during medical school vaccina-
tion. * DSV > BSV. ** p = 0.00 - Female > male. Mann-Whitney test.
Table 3
Frequency of medical students enrolled in the 3rd through 6th academic years 
who reported previous exposures to blood or secretions
Academic years Frequency of occupational exposures
N %
Third (N = 61) 3 4.9
Fourth (N = 48) 6 12.5
Fifth (N = 51) 16 31.4
Sixth (N = 60) 27 45.0
Total (N = 220) 52 23.6
N = number of students.
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dose26. In the present study, 15.9% of women and 29.7% of men (19.6% 
of the total number of students) had levels of anti-HBs between 10 and 
99 IU/L, results similar to those found by OATES et al.11 (1993) among 
clinical medical students at Birmingham Medical School, in the United 
Kingdom.
Protective levels of anti-HBs antibody are present in approximately 
50% of young adults after one dose of vaccine against hepatitis B and 
in 85% after two doses3. In the present study, 85.7% of female students 
who received two doses of vaccine had levels of anti-HBs higher than 
10 IU/L; the small number of male students who received one or two 
doses and of female students who received one dose does not enable an 
analysis to be made. However, even when there is an immunological 
response to vaccination after two doses, the third dose is required to 
provide long-term immunity3.
Only 11% of the students had undergone tests to assess the response 
to vaccination before this study was performed. This is a cause for 
concern, because several students who participated in this study had anti-
HBs titers lower than 10 IU/L. Students need to be instructed to check 
their serum levels of anti-HBs after receiving all recommended three 
doses of HB vaccine, especially male students and those who had been 
vaccinated before entering university. Students who do not respond to the 
initial three doses, the booster dose, and the second series of vaccines, 
are at risk of acquiring hepatitis B and should be advised about how to 
prevent an HBV infection and how to perform prophylaxis in case such 
contact occurs. The frequency of spontaneous searches to find out post-
vaccination immunity status, as observed in this study, is lower than that 
found in another study, in the United Kingdom (64%), where prevalence 
of hepatitis B is low11; this reveals the need to raise students’ awareness 
of the importance of such an assessment. 
Among the students who were in the last year of the course of 
medicine, almost half of them had suffered a potentially contaminating 
accident during their clinical course, whether with a needle stick or sharp 
object or through secretions coming in contact with mucosa. Some of the 
studies addressing the frequencies of needle-stick injuries among medical 
students in other countries reported rates varying between 14.6% and 
41%5,6,13,21, while frequencies of injuries due to body fluids coming in 
contact with mucosa was 8%17 and 20%12. In another study performed 
in Brazil, the frequency of accidents associated with the training of 
medical students was 52.3% among those who were in the last semester 
of the course, most of which involving needle sticks or sharp objects15.
There were no differences in frequencies of accidents between 
male and female students. These results differ from those of two other 
studies: one with Australian medical students, in which the frequencies 
of injuries was 71.4% in women and 28.6% in men20, and the other from 
Iran, in which the frequencies of injuries was 73.1% in men and 26.9% 
in women19.
Although such accidents are usually stressful events, only 44.2% of 
students exposed sought medical care. Alleged reasons for not seeking 
care were either not considering this as important in the situation or 
feeling embarrassed to do this. Despite the known risks of acquiring 
infections inherent in such accidents, not seeking care or not reporting 
the fact to the proper authorities has been observed in several studies 
and regions, with frequencies varying between 41% and 75%6,8,13,15,24. 
In a study performed in the university hospital of Erlangen, Germany, 
only 18.8% of students sought a doctor after the first incident of body 
fluids coming in contact with mucosa, whereas none sought medical care 
after the second or third incidents17. In another study, where half of the 
students reported having had needle-stick accidents, it was observed that 
76% of those evaluated did not have any knowledge about post-exposure 
prophylaxis for hepatitis B or C10. The alleged reasons usually given by 
students for not seeking medical care were as follows: accident having 
been forgotten, underestimation of the risk, being reluctant to admit 
lack of knowledge about handling certain instruments, avoiding the 
inconvenience of a report and follow-up, and being afraid of a positive 
serological test result17.
Data from the present study show that the frequency of vaccination 
against HBV is high among the evaluated medical students enrolled in the 
clinical course, although they were not concerned about the verification 
of serological response to the anti-HB vaccine. Upon admission to the 
school of medicine, history of vaccination against HB and serological 
markers of HBV infection (HBsAg, anti-HBs and anti-HBc) should be 
determined. Students who have not been vaccinated and who have not 
had previous contact with HBV should always be aware of the need 
for vaccination. Determination of serum anti-HBs titers after complete 
vaccination and on a regular basis should not be neglected, especially 
not by men. 
Moreover, during the clinical course, it was observed that accidents 
caused by contact with blood or secretions are frequent, which should 
promote institutional policies on vaccination against hepatitis B and 
preventive educational practices against such accidents. The universal 
precautions4 to handle needles or cutting objects and to protect oneself 
against secretions should be taught and emphasized. Results of the present 
study show that this should be performed at least at the end of the pre-
clinical stage and beginning of the clinical stage of the course. In addition, 
it is necessary to maintain a blood and body fluid post-exposure report 
system, raise students’ awareness, encourage them to report occupational 
accidents, and provide post-exposure care. 
RESUMO
Frequências de imunidade para hepatite B e de exposição 
ocupacional a fluídos corpóreos entre estudantes de medicina em 
uma universidade pública brasileira
Neste estudo avaliaram-se as freqüências de imunidade contra 
a hepatite B (HB) e de acidentes potencialmente contaminantes 
em estudantes de medicina de uma universidade pública brasileira. 
Responderam um questionário anônimo e auto-aplicável 303 de 400 
estudantes (75,7%) que já deveriam estar imunizados contra a HB, sendo 
66,3% do sexo feminino. Anti-HBs séricos foram determinados em 205 
deles e títulos ≥ 10 UI/L foram considerados como protetores. Tinham 
esquema vacinal completo 86,8% dos alunos. A freqüência de imunidade 
entre as mulheres (96,4%) foi maior (p = 0,04) do que entre os homens 
(87,7%). Entre os que não tinham imunidade, 12/13 (92,3%) tinham sido 
vacinados antes de ingressarem no curso de medicina. Somente 11% 
dos alunos com vacinação completa tinham, previamente, verificado a 
resposta sorológica à vacina. Do total de alunos, 23,6% relataram algum 
acidente potencialmente contaminante, e entre aqueles do último ano 
esta freqüência foi de 45,0%, sendo semelhante entre homens (47,8%) e 
mulheres (43,2%). De todos estes acidentes, 57,7% foram com secreções 
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e 42.3% devido a acidentes perfuro-cortantes. Os resultados mostram que: 
1) entre os estudantes avaliados é alta a freqüência de imunidade contra 
a HB, mas a verificação da resposta à vacinação não é uma preocupação 
entre eles; 2) a verificação dos títulos de anti-HBs deveria ser realizada 
após o esquema vacinal completo e periodicamente, principalmente 
entre os homens; e 3) é alta a freqüência de acidentes potencialmente 
contaminantes. 
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